Turn Therapeutics (TTRX) announced the launch of a broad communications initiative, featuring a recurring webinar series for shareholders and a forthcoming Founder Blog authored by patient-turned-founder and CEO, Bradley Burnam. The Founder Blog will publicly share ongoing company updates, research insights, and perspectives on Turn’s growth and innovation. Further details about the blog will be announced later this week. The webinar series will provide live discussion covering ongoing programs, strategic milestones, and upcoming developments. The first live session will take place on Wednesday, October 22, 2025, at 2:00 PM ET via webcast.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TTRX:
- Turn Therapeutics appoints Kester to board of directors
- Turn Therapeutics files to sell 7M shares off common stock for holders
- Turn Therapeutics Inc. Common Stock trading resumes
- Turn Therapeutics Inc. Common Stock trading halted, volatility trading pause
- Turn Therapeutics commences trading on Nasdaq